A friend from a auto detailing shop specializing in magwheels along Santolan told me out of 19 staff who took antigen tests, only 3 were negative. They didn't bother taking RT-PCR and will just close for one week. A bank in Sta Cruz with only 3 remaining staff who had no symptoms took antigen test and all were positive.
Talagang economic disruption nangyayari kahit "mild" symptoms lang.
In short the data is useless for analysis purposes? I hope that powers that decides the next step the government will take has a more accurate, time adjusted data than what doh releases to the public. I mean, I think the 33k new cases today eh hindi lang today or for last 3 days.
Sent from my EB2103 using Tapatalk
With the current rate this is going, I wonder if anyone will be able to escape catching it this round?
Stay out of the hospital?
-Likely.
Survive?
-Probably a good chance.
But not get infected... I don't know.
"mugunghwa kkochi pieot seumnida..." [BANG!]
"mugunghwa kkochi pieot seumnida..." [BANG! BANG! BANG!]
Well, the dead don't speak AHAHAHA
If they did eh, mas nakakatakot siguro yun![]()
U.S. decoupling between cases, hospitalizations, deaths, while measurable vs prior waves, isn't as strong as UK; perhaps due to lower U.S. vax/booster rates (50% eligible adults boosted). Our protracted wrangling over boosters may have sowed confusion, sapping consumer interest
![]()
Last edited by Monseratto; January 10th, 2022 at 08:31 PM.
T-cells from common colds can provide protection against COVID-19 - study | Reuters
The study, which began in September 2020, looked at levels of cross-reactive T-cells generated by previous common colds in 52 household contacts of positive COVID-19 cases shortly after exposure, to see if they went on to develop infection.
It found that the 26 who did not develop infection had significantly higher levels of those T-cells than people who did get infected. Imperial did not say how long protection from the T-cells would last.
"We found that high levels of pre-existing T cells, created by the body when infected with other human coronaviruses like the common cold, can protect against COVID-19 infection," study author Dr Rhia Kundu said.
"In contrast, the internal proteins targeted by the protective T-cells we identified mutate much less," Professor Ajit Lalvani, co-author of the study, said.
"Consequently, they are highly conserved between the various SARS-CoV-2 variants, including Omicron. New vaccines that include these conserved, internal proteins would therefore induce broadly protective T cell responses that should protect against current and future SARS-CoV-2 variants."